Skip to main content
All lobbying filings

BELL & LINDSAY, INC.

Lobbying for OYE THEREPEUTICS · Pharmaceutical, development stage, company

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Indiana · House · Senate · $10,000.00 income · posted Feb 11, 2026

Official filing document

 Lobbying activity 1
Health Issues

General Consulting and informing federal agencies and Congress on the research that OYE Therapeutics is currently doing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem